{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "currency": "EUR", "market": "dr_market", "esgPopulated": false, "gmtOffSetMilliseconds": 7200000, "exchange": "FRA", "longName": "Atara Biotherapeutics, Inc.", "shortName": "ATARA BIOTHERAP. DL-,0001", "regularMarketPrice": 2.102, "regularMarketChangePercent": 0.6223079, "messageBoardId": "finmb_248196818", "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.75755477, "fiftyTwoWeekLow": 2.089, "fiftyTwoWeekHigh": 8.67, "earningsTimestamp": 1683576060, "earningsTimestampStart": 1691405940, "earningsTimestampEnd": 1691755200, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "fiftyTwoWeekLowChange": 0.013000011, "fiftyTwoWeekLowChangePercent": 0.006223079, "fiftyTwoWeekRange": "2.089 - 8.67", "fiftyTwoWeekHighChange": -6.568, "epsTrailingTwelveMonths": -1.64, "epsForward": -3.55, "epsCurrentYear": -3.7, "priceEpsCurrentYear": -0.5681081, "sharesOutstanding": 96628800, "bookValue": 0.673, "fiftyDayAverage": 2.76332, "fiftyDayAverageChange": -0.66132, "fiftyDayAverageChangePercent": -0.23932081, "twoHundredDayAverage": 3.714265, "twoHundredDayAverageChange": -1.6122651, "twoHundredDayAverageChangePercent": -0.43407378, "marketCap": 255039856, "forwardPE": -0.59211266, "priceToBook": 3.1233284, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "1.8 - Buy", "tradeable": false, "cryptoTradeable": false, "firstTradeDateMilliseconds": 1414393200000, "priceHint": 4, "regularMarketChange": 0.013000011, "regularMarketTime": 1683871451, "regularMarketDayHigh": 2.102, "regularMarketDayRange": "2.102 - 2.102", "regularMarketDayLow": 2.102, "regularMarketVolume": 90, "regularMarketPreviousClose": 2.089, "bid": 1.941, "ask": 1.965, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 2.102, "averageDailyVolume3Month": 3, "averageDailyVolume10Day": 0, "symbol": "AT2.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "2380 Conejo Spectrum Street", "address2": "Suite 200", "city": "Thousand Oaks", "state": "CA", "zip": "91320", "country": "United States", "phone": "805 623 4211", "website": "https://www.atarabio.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Atara Biotherapeutics, Inc. develops therapies for patients with solid tumors, hematologic cancers, and autoimmune diseases in the United States. Its lead product includes Tab-cel (tabelecleucel), a T-cell immunotherapy program that is in Phase 3 clinical trials for the treatment of epstein-barr virus (EBV) driven post-transplant lymphoproliferative disease, as well as nasopharyngeal carcinoma. Its CAR T immunotherapy pipeline products include ATA2271 and ATA3271 to treat mesothelin; and ATA3219 for the treatment of B-cell malignancies, as well as ATA188 that is in Phase 2 clinical trials to treat multiple sclerosis. Atara Biotherapeutics, Inc. has a license agreement with Memorial Sloan Kettering Cancer Center; license, and research and development collaboration agreement with QIMR Berghofer Medical Research Institute; and strategic collaboration with H. Lee Moffitt Cancer Center. The company was incorporated in 2012 and is headquartered in Thousand Oaks, California.", "fullTimeEmployees": 334, "companyOfficers": [{"maxAge": 1, "name": "Dr. Pascal  Touchon D.V.M.", "age": 58, "title": "Pres, CEO & Director", "yearBorn": 1964, "fiscalYear": 2022, "totalPay": {"raw": 1077856, "fmt": "1.08M", "longFmt": "1,077,856"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Charlene A. Banard", "age": 59, "title": "Exec. VP & Chief Technical Officer", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 753089, "fmt": "753.09k", "longFmt": "753,089"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. K. Amar Murugan", "age": 46, "title": "Exec. VP & Chief Legal Officer", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 618524, "fmt": "618.52k", "longFmt": "618,524"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jakob  Dupont M.D.", "age": 57, "title": "Exec. VP and Global Head of R&D", "yearBorn": 1965, "fiscalYear": 2022, "totalPay": {"raw": 750530, "fmt": "750.53k", "longFmt": "750,530"}, "exercisedValue": {"raw": 64250, "fmt": "64.25k", "longFmt": "64,250"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Eric  Hyllengren", "age": 47, "title": "Sr. VP & CFO", "yearBorn": 1975, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Anhco  Nguyen", "age": 49, "title": "Chief Scientific Officer", "yearBorn": 1973, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Kerry Beth Daly", "title": "Head of Corp. Communications", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Joseph  Newell", "age": 52, "title": "Exec. VP", "yearBorn": 1970, "fiscalYear": 2020, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Manher  Joshi", "title": "Chief Medical Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Ms. Jill  Henrich", "age": 59, "title": "Head of Global Regulatory Affairs", "yearBorn": 1963, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 7, "boardRisk": 4, "compensationRisk": 7, "shareHolderRightsRisk": 8, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}